KIR7.1 Antibodies

Santa Cruz Biotechnology offers a broad range of KIR7.1 monoclonal antibodies for research focused on understanding KIR7.1 protein functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KIR7.1, a member of the killer immunoglobulin-like receptor (KIR) family, plays a crucial role in the immune response by regulating the activity of natural killer (NK) cells. KIR7.1 expression is fundamental for maintaining immune homeostasis and can influence the outcome of various diseases, including cancer and autoimmune disorders. Understanding KIR7.1 function is essential for developing targeted therapies and improving immunological interventions. Researchers can utilize KIR7.1 monoclonal antibodies to explore cellular pathways and molecular mechanisms involved in immune regulation. Current studies with KIR7.1 monoclonal antibodies are uncovering new insights into immune system function and disease progression. The high-quality KIR7.1 monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of immune system regulation and disease mechanisms.